Maximilian Pfau
@MaximilianPfau3
Followers
100
Following
148
Media
10
Statuses
58
What a brilliant keynote by @MaximilianPfau3 đđ Congratulations! So we'll deserved
0
1
1
Establishing Fully-Automated Fundus-Controlled Dark Adaptometry: A Validation and Retest-Reliability Study
medrxiv.org
Purpose To establish and validate a novel fundus-controlled dark-adaptometry method. Methods We developed a custom dark-adaptometry software for the S-MAIA device using the open perimetry interface....
0
0
3
Our latest work: Natural-History of Visual Dysfunction in ABCA4-retinopathy and its Genetic Correlates https://t.co/hebR7NY8cz
@NatEyeInstitute @IOB_ch
0
0
1
Read more about the exciting new results of a collaboration between IOB and @BeamTx on developing a precision gene editing therapy for blindness here
biorxiv.org
Stargardt disease is a currently untreatable, inherited neurodegenerative disease that leads to macular degeneration and blindness due to loss-of-function mutations in the ABCA4 gene. We have...
0
2
4
Kristina Pfau @KristinaHessMD et al. @UniklinikBonn quantify choriocapillaris flow alterations in patients with pseudoxanthoma elasticum (PXE) in pre-atrophic stages and its association with structural changes of the choroid and outer retina. https://t.co/lCiWlNstxp
1
3
6
Aufgepasst! Am @IOB_ch lĂ€uft gerade die Bewerbungsphase fĂŒr das neue MD/PhD-Programm "Translational Visual #Neurosciences". Wer zum #Auge, zur Verarbeitung visueller EindrĂŒcke und zu neuen Therapien forschen will, kann sich bis zum 18. November bewerben! https://t.co/R3iK5EILL8
â The countdown is on: only two weeks left to apply for our IOB PhD and MD-PhD program on Translational Visual Neurosciences. Follow this link to apply until November 18th and join our team! https://t.co/FbLc5A9LBm
0
1
1
La clinique ophtalmologique de lâHĂŽpital universitaire de BĂąle recherche actuellement des participants pour l'Ă©tude âFirst Orbitâ. Un traitement pour la maladie de Stargardt associĂ©e Ă le G1961E variant est actuellement en cours de dĂ©veloppement. https://t.co/etgXdygK7R
0
2
2
La clinique ophtalmologique de lâHĂŽpital universitaire de BĂąle recherche aussi actuellement des participants pour lâĂ©tude dâĂ©volution naturelle Pro-PXE (Progression Rate of Pseudoxanthoma Elasticum-related Choroidal and Retinal Degeneration). https://t.co/2Tz5YJvvye
retina.ch
etude-pro-pxe-recherche-de-participants, etude-pro-pxe-recherche-de-participants La clinique ophtalmologique de lâHĂŽpital universitaire de BĂąle recherche actuellement des participants Ă lâĂ©tude...
0
1
1
Combining traditional eye imaging + adaptive optics⊠Johnny Tam & colleagues (@NatEyeInstitute intramural) show for the 1st time how RPE cells are affected in people with choroideremia. @RongwenLu @MaximilianPfau3 @HufnagelLab @LaryssaHuryn
@CommsBio: https://t.co/6SkZmRzmyB
0
9
21
Association of Complement C3 Inhibitor Pegcetacoplan with Photoreceptor Degeneration Beyond Areas of Geographic Atrophy https://t.co/keUWl5h8Bb
#medRxiv
0
1
2
Just out in Neuron! Across cortical layers, only layer 5 pyramidal neurons synchronize their activity during anesthesia-induced loss of consciousness. #neuroscience #anesthesiology #research @IOB_Roska @NeuroCellPress
2
22
80
New Manuscript: Choriocapillaris Flow Signal Impairment in Sorsby Fundus Dystrophy https://t.co/XkVl0gmQM4
@KristinaHessMD @YoungRetina @ProRetinaDe @NatEyeInstitute
karger.com
Abstract. Purpose: The aim of the study was to quantify choriocapillaris (CC) flow alterations in early Sorsby fundus dystrophy (SFD) and to investigate the relationship of the CC flow deficits with...
0
1
6
#NEIfunded research classifies vision loss and retinal changes in Stargardt disease . Learn how: https://t.co/lnpmsSgvnh
0
7
18
Schmitz-Valckenberg et al. Progression of Age-Related Macular Degeneration Among Individuals Homozygous for Risk Alleles on Chromosome 1 (CFH-CFHR5) or Chromosome 10 (ARMS2/HTRA1) or Both https://t.co/wUIYqnbSwN
@NatEyeInstitute @MoranEyeCenter @JAMAOphth
0
1
5
Our latest research on the genotype-phenotype relationship in Stargardt disease. @NatEyeInstitute @JCI_insight
https://t.co/QAQY16FR9m
0
3
11
Inner Retinal Degeneration in Pseudoxanthoma Elasticum Summary: Given the severity of inner retinal degeneration in a subset of PXE patients, a clinical trial investigating neuroprotective therapy warrants consideration. https://t.co/eUnOYnBKon
@KristinaHessMD @pxe @UniklinikBonn
0
0
4
Very excited to move my research forward with VERI. If you are interested in any of the work I do please get in touch to discuss opportunities to work together or work on a PhD project. I work hard on inclusivity so welcome queries from all backgrounds.
We are delighted to announce that Dr @JKJolly4 has joined @AngliaRuskin as an Associate Professor. Her work combines #Optometry, #Ophthalmology, #Neuroscience, #Psychology, and other disciplines to improve patient care and disease understanding. Welcome to the VERI team Dr Jolly!
10
9
44
Reading Performance in Geographic Atrophy Secondary: The topography of #GeographicAtrophy and central acuity explain ~70% of the variability in reading acuity and speed. @UniklinikBonn @MoranEyeCenter @MoritzLindner2 @Ophthalmologen @NatEyeInstitute
Study supports the validity of reading performance as endpoint in clinical trials and suggests that measures in clinical and low vision care of patients with geographic atrophy secondary to AMD should focus primarily on the better-seeing eye
0
2
4
Study supports the validity of reading performance as endpoint in clinical trials and suggests that measures in clinical and low vision care of patients with geographic atrophy secondary to AMD should focus primarily on the better-seeing eye
0
3
7
For the clinical application of AI, accurate point predictions are not sufficient. A correct estimate of the uncertainty for each prediction is necessary to highlight cases, that require human inspection. AMD study based on the NGBoost library from the @AndrewYNg group
New and free to read: "Probabilistic Forecasting of #AntiVEGF Treatment Frequency in Neovascular #AMD.â Full article: https://t.co/CsuBvpeJkK
#MachineLearning #SDOCT #retina #biomarkers #PersonalizedMedicine #ophthalmology #OpenAccess
0
3
20